CAS 99624-28-9: 4-[(2S)-3,4-Dihydro-7-hydroxy-2H-1-benzopyran-2-yl]-3,6-bis(3-methyl-2-buten-1-yl)-1,2-benzenediol

Kazinol A inhibits AA-induced platelet aggregation and XOD with IC50 of 0.6-164 µM; may fight bladder cancer, even cisplatin-resistant.

Kazinol A is a natural flavonoid, which is sourced from the roots of certain traditional medicinal plants, chiefly within the Moraceae family such as Broussonetia kazinoki. This compound primarily exhibits its mode of action through modulation of various biochemical pathways, often involving the inhibition of microbial growth. As a potent antioxidant, it also impacts cellular oxidative stress levels. Kazinol A is utilized in scientific research for its potential antimicrobial, anti-inflammatory, and anticancer properties. Studies have demonstrated its effectiveness in inhibiting the growth of certain bacteria and fungi, as well as its potential to interfere with carcinogenesis. Researchers are exploring its applications in developing novel pharmaceutical agents, particularly in the areas of infectious diseases and cancer therapy. Its diverse bioactivity profiles make it a subject of significant interest among scientists aiming to harness natural compounds for therapeutic purposes.